Shots:
CDMOs have become central to the modern biopharmaceutical ecosystem, helping companies accelerate development timelines, navigate rising technical complexity, and bring innovative therapies to market with greater efficiency
The global CDMO market continues to post strong double-digit growth and is projected to reach nearly $255B by 2025. This momentum is driven by increased outsourcing, the…
Shots:
Epilepsy affects around 1.5 million people in the US and 50 million globally. With approximately 40% of epilepsy patients being drug-resistant, there is an urgent need for innovative therapies
Today, at PharmaShots we have Dr. Jason Lerner from Biohaven shedding light on BHV-7000, an investigational anti-seizure treatment and selective activator of potassium channels in…
Knowledge-packed, informative, and engaging, the Reuters Pharma 2024 event brimmed with enlightening sessions, presentations, and scientific orators shedding light on innovative therapies and unmet needs of the healthcare sector.
Day 1 commenced with keynote speakers shedding light on next-generation customer engagement models, mastering patient-centric metrics, amplifying strategic voice, and expediting equitable access followed by a…

